The interesting play here might be the Swedish company Active Biotech (NASDAQ OMX NORDIC: ACTI) which was down very sharply indeed.
Looks like ACTI was down over 50%. I assume your initial thoughts here on ACTI have changed as a result of the follow-on discussion regarding the Avonex results beating the placebo. If not, curious to hear more on why you think ACTI may be an interesting play.
Market Data 
Markets 
AI
